Recent News

• 06.12.2025 - Ionis announces Dr. Richard Geary, chief development officer, to retire; Dr. Holly Kordasiewicz to assume role in January 2026
• 06.11.2025 - First patient dosed in pivotal Phase 3 REVEAL clinical study of ION582 in Angelman syndrome
• 06.05.2025 - 2025 Virtual Annual Meeting of Stockholders Corporate Update
• 06.05.2025 - 2025 Virtual Annual Meeting of Stockholders (for stockholders of record as of April 7, 2025)
• 05.21.2025 - 2025 RBC Capital Markets Global Healthcare Conference
• 05.21.2025 - 2025 RBC Capital Markets Global Healthcare Conference
• 05.21.2025 - 2025 RBC Capital Markets Global Healthcare Conference
• 05.19.2025 - Ionis announces positive topline results from Essence study of olezarsen in people with moderately elevated triglycerides
• 05.14.2025 - Bank of America 2025 Health Care Conference
• 05.14.2025 - Bank of America 2025 Health Care Conference

Recent Filings

• 06.12.2025 - 8-K Current report
• 06.12.2025 - EX-99.1 EX-99.1
• 06.10.2025 - 8-K Current report
• 05.19.2025 - 8-K Current report
• 05.19.2025 - EX-99.1 EX-99.1
• 05.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.30.2025 - EX-99.1 EX-99.1